ACAN
vs
S&P 500
ACAN
S&P 500
Over the past 12 months, ACAN has underperformed S&P 500, delivering a return of -100% compared to the S&P 500's +14% growth.
Stocks Performance
ACAN vs S&P 500
Performance Gap
ACAN vs S&P 500
Performance By Year
ACAN vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Americann Inc
Glance View
Americann, Inc. engages in the development and leasing of cannabis cultivation, processing and product manufacturing facilities. The company is headquartered in Denver, Colorado and currently employs 3 full-time employees. The company went IPO on 2013-09-10. The firm is developing product manufacturing and greenhouse cultivation facilities. Its flagship project is the Massachusetts Cannabis Center. The Massachusetts Cannabis Center (MCC) is being developed on an approximately 52-acre parcel located in Southeastern Massachusetts. Its MCC project is permitted for approximately 987,000 square feet of cannabis cultivation and processing infrastructure, which is being developed in phases to support both the existing medical cannabis and the newly emerging adult-use cannabis marketplace. Its first phase of the million square feet project, Building 1, is about 30,000 square feet. The firm through its subsidiary, AmeriCann Brands, Inc., has received two licenses from the Massachusetts Cannabis Control Commission to cultivate cannabis and provide extraction and product manufacturing support to the entire MCC project, as well as to other licensed cannabis farmers throughout regulated markets.
